Immunologic epitope, gene, and immunity involved in pneumococcal glycoconjugate

Critical Reviews in Microbiology

Volumn 23, Issue 2, 1997, Pages 121-142

  Lee, Chi Jen ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Conjugate vaccine; Monoclonal antibody; Pneumolysin gene; Protective immunity

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BINDING PROTEIN; EPITOPE; GLYCOCONJUGATE; HEMIN; MONOCLONAL ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; PNEUMOLYSIN; RABBIT ANTISERUM; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; CLINICAL TRIAL; HUMAN; IMMUNITY; IMMUNOGENICITY; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; PNEUMOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030840834     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408419709115133     Document Type: Review

References (26)

1. Istre, G. R., Tarpay, M., Anderson, M., Pryor, A., and Welch, D., Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance, J. Infect. Dis.., 156, 732, 1987.
2. Lee, C. J. and Wang, T.R., Pneumococcal infection and immunization in children, Crit. Rev. Microbiol., 20(1), 1, 1994.
3. Bluestone, C. D. Stephenson, J. S., and Martin, L. M., Ten-year review of otitis media pathogens, Paediatr. Infect. Dis., 11(Suppl. 8), S7, 1992.
4. Bluestone, C. D., and Klein, J. O., Otitis media, atelectasis. and eustachian tube dysfunction, in Pediatric Otolaryngology, Bluestone, C. D., Stool, S. E., amd Scheetz, M D., Eds., W.B. Saunders, Philadelpia, 1990,320.
5. Immunization Practice Advisory Committee, Pneumococcal polysaccharide vaccine, Mort. Morb. Wk. Rep., 38, 64, 1989.
6. Williams, W. W., Hickson, M. A., Kane, M. A., Kendal, A. P., Spika, J. S., and Hinman, A. R., Immunization policies and vaccine coverage among adults: the risk for missed opportunities, Ann. Intern. Med., 108, 616, 1988.
7. Giebink, G. S., The microbiology of otitis media, Pediatr. Infect. Dis.., 8, S18, 1989.
8. Teele, D. W., Klein, J. O., and Rosner, B. A., Epidemiology of otitis media in children, Ann. Otol. Rhin. Laryngol., 89(Suppl. 68), 5, 1980.
9. Jacobs, N. M., Lerkachornsuk, S., and Metzger, W. I., Pneumococcal bacteremia in infants and children: a 10-year experience at the Cook County Hospital with special reference to the pneumococcal serotypes isolated, Pediatrics, 64, 296, 1979.
10. Gray, B. M. and Dillon, H. C., Jr., Clinical and epidemiologic studies of pneumococcal infection in children, Peditr. Infect. Dis. J., 5, 201, 1986.
11. Johnston, R. B., Pathogenesis of pneumococcal pneumonia, Rev, Infect. Dis., 13(Suppl. 6), S509, 1991.
12. Gray, B. M., Converse, G. M., III, and Dillon, H. C., Jr., Serotypes of Streptococcus pneumoniae causing disease, J. Infect. Dis., 140, 979, 1979.
13. Ishizaka, A., Pneumococcal vaccine, Pediatr. Diag., 59(1), 101, 1996.
14. Matsumoto, K., Pneumococcal vaccine: from treatment to prevention, Med. Biol., 6(5), 117, 1989.
15. Murai, T. and Takayanagi, M., Pneumococcal infection - Streptococcus pneumoniae and vaccine, Pediatr. Int. Med.., 21, 897, 1989.
16. Division of Microbiology and Infectious Diseases, NIAID, NIH, Streptococcus pneumoniae, In The Jordan Report: Acceleratred Development of Vaccines 1995, La Montagne, M., Ed., National Institute of Allgery and Infectious Diseases, NIH, Bethesda, MD, 1995, 18.
17. Breiman, R. F., Butler, J. C., Tenover, F. C., Elliott, J. A., and Facklan, R. R., Emergence of drug-resistant infections in the United States, JAMA, 271, 1831, 1994.
18. Simberkoff, M. S., Drug-resistant pneumococcal infections in the United States: a problem for clinicians, laboratories, and public health, JAMA, 271, 1875, 1994.
19. Friedland, I. R. and McCracken, G. H., Management of infections caused by antibiotic-resistant Streptococcus pneumoniae, N. Eng. J. Med., 331, 377, 1994.
20. Fairchild, R. L, Sterner, K. E., and Braley-Mullen, H., Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies, Infect. Immun., 52, 867, 1986.
21. Sorensen, U. S., Agger, R., Rennedsen, R., and Henrichsen, J., Phosphorylchlorine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody, Infect. Immun., 43, 876, 1984.
22. Lee, C. J., Karpas, A., Wang, T. R., Kosaka, T., and Koizumi, K., Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type 9V conjugate, Microbiol. Imimmol., 40(11), 857, 1996.
23. Bishop, C. T. and Bwnnet, L. G., Structure of the type XXXHI Streptococcus pneumoniae (pneumococcus) capsular poly saccharide, Can. J. Chem., 58, 2724, 1980.
24. Richards, J. C., Perry, M. B., and Kniskern, P. J., Structural analysis of the specific polysaccharide of Streptococcus pneumoniae type 9L (American type 49), Can. J. Biochem. Cell Biol., 62, 1309, 1984.
25. Jones, C., Mulloy, B., Wilson, A., Dell, A., and Oates, J. E., Structure of the capsular polysaccharide from Streptococcus pneumoniae type 9, J. Chem. Soc. Perkin. Trans, 1, 1665, 1985.
26. Perry, M. B., Daoust, V., and Carlo, D. J., The specific capsular polysaccharide of Streptococcus pneumoniae-type 9V, Can. J. Biochem., 59, 524, 1981.